X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with VENUS REMEDIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. VENUS REMEDIES FDC LTD./
VENUS REMEDIES
 
P/E (TTM) x 24.3 -898.2 - View Chart
P/BV x 5.1 0.3 1,930.6% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 FDC LTD.   VENUS REMEDIES
EQUITY SHARE DATA
    FDC LTD.
Mar-14
VENUS REMEDIES
Mar-16
FDC LTD./
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs144218 65.8%   
Low Rs7982 96.2%   
Sales per share (Unadj.) Rs47.6365.6 13.0%  
Earnings per share (Unadj.) Rs7.61.5 512.1%  
Cash flow per share (Unadj.) Rs9.037.9 23.8%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.5382.5 12.4%  
Shares outstanding (eoy) m177.8311.44 1,554.5%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.30.4 569.9%   
Avg P/E ratio x14.6101.0 14.5%  
P/CF ratio (eoy) x12.34.0 312.0%  
Price / Book Value ratio x2.30.4 596.7%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,7841,717 1,152.5%   
No. of employees `000NA1.0 0.0%   
Total wages/salary Rs m1,221324 376.2%   
Avg. sales/employee Rs ThNM4,100.7-  
Avg. wages/employee Rs ThNM318.0-  
Avg. net profit/employee Rs ThNM16.7-  
INCOME DATA
Net Sales Rs m8,4594,183 202.2%  
Other income Rs m39420 1,958.0%   
Total revenues Rs m8,8524,203 210.6%   
Gross profit Rs m2,070812 255.1%  
Depreciation Rs m249417 59.8%   
Interest Rs m31380 8.2%   
Profit before tax Rs m2,18435 6,221.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m60618 3,345.6%   
Profit after tax Rs m1,35317 7,959.7%  
Gross profit margin %24.519.4 126.1%  
Effective tax rate %27.751.6 53.8%   
Net profit margin %16.00.4 3,936.0%  
BALANCE SHEET DATA
Current assets Rs m4,3552,771 157.2%   
Current liabilities Rs m1,7921,931 92.8%   
Net working cap to sales %30.320.1 151.0%  
Current ratio x2.41.4 169.4%  
Inventory Days Days44125 35.5%  
Debtors Days Days2554 45.9%  
Net fixed assets Rs m3,0255,328 56.8%   
Share capital Rs m179114 156.1%   
"Free" reserves Rs m8,2434,177 197.3%   
Net worth Rs m8,4534,376 193.2%   
Long term debt Rs m111,911 0.6%   
Total assets Rs m10,5578,428 125.3%  
Interest coverage x71.41.1 6,537.4%   
Debt to equity ratio x00.4 0.3%  
Sales to assets ratio x0.80.5 161.4%   
Return on assets %13.14.7 278.5%  
Return on equity %16.00.4 4,120.9%  
Return on capital %23.56.6 356.2%  
Exports to sales %13.30-   
Imports to sales %3.320.5 16.3%   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283858 32.9%   
Fx inflow Rs m1,1460-   
Fx outflow Rs m355858 41.4%   
Net fx Rs m791-858 -92.1%   
CASH FLOW
From Operations Rs m1,485469 316.7%  
From Investments Rs m-62029 -2,121.6%  
From Financial Activity Rs m-753-464 162.4%  
Net Cashflow Rs m11335 327.0%  

Share Holding

Indian Promoters % 68.9 32.9 209.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 0.2 2,611.1%  
FIIs % 7.5 0.6 1,293.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 66.4 28.6%  
Shareholders   23,730 20,121 117.9%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   DR. REDDYS LAB  IPCA LABS  JUBILANT LIFE SCIENCES  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets Trade Flat; TCS Surges 3.5%(01:30 pm)

Indian share markets continued to trade on a flat note in the noon session. Gains are largely seen in software stocks, bank stocks and capital goods' stocks.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jan 16, 2018 03:35 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - NOVARTIS COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS